A review of somatic genome aging in women establishes loss of the X chromosome (LOX) in blood cells as the most common acquired mutation in females, detectable in over 10% of women aged 55 and older with frequency and clone size rising steeply with age. LOX preferentially affects the inactivated X chromosome, impairs cellular function, and is associated with hematological malignancies as well as a range of non-malignant conditions. The finding positions clonal chromosomal loss in blood as a measurable, sex-specific marker of biological aging.
Key Points
- Over 10% of women aged 55+ show detectable X loss in blood
- LOX linked to blood cancers and multiple benign conditions
- Lifestyle and environmental stressors shape LOX acquisition and clonal expansion
Longevity Analysis
Blood-forming stem cells accumulate structural genomic damage decades before clinical disease appears, and the resulting mutant clones compromise immune surveillance and tissue renewal rather than simply marking elapsed time. Because clonal expansion is modulated by inherited variants alongside environmental and lifestyle exposures, the trajectory is partly modifiable — removing chronic genotoxic and inflammatory burden matters more than any downstream intervention. Sequencing-based detection of chromosomal loss in peripheral blood offers a female-specific readout of regenerative capacity, paralleling the role mosaic Y loss plays in men and giving clinicians an early signal worth tracking.
Original published by Wiley Aging Cell, by Xihan Guo, Xueqin Dai .